全文获取类型
收费全文 | 375篇 |
免费 | 46篇 |
国内免费 | 1篇 |
专业分类
儿科学 | 2篇 |
妇产科学 | 2篇 |
基础医学 | 11篇 |
口腔科学 | 8篇 |
临床医学 | 41篇 |
内科学 | 294篇 |
神经病学 | 10篇 |
特种医学 | 7篇 |
外科学 | 21篇 |
综合类 | 4篇 |
预防医学 | 11篇 |
药学 | 6篇 |
肿瘤学 | 5篇 |
出版年
2023年 | 14篇 |
2022年 | 1篇 |
2021年 | 18篇 |
2020年 | 11篇 |
2019年 | 17篇 |
2018年 | 21篇 |
2017年 | 16篇 |
2016年 | 4篇 |
2015年 | 14篇 |
2014年 | 16篇 |
2013年 | 22篇 |
2012年 | 34篇 |
2011年 | 20篇 |
2010年 | 15篇 |
2009年 | 11篇 |
2008年 | 19篇 |
2007年 | 23篇 |
2006年 | 11篇 |
2005年 | 26篇 |
2004年 | 18篇 |
2003年 | 9篇 |
2002年 | 8篇 |
2001年 | 15篇 |
2000年 | 8篇 |
1999年 | 9篇 |
1998年 | 2篇 |
1997年 | 1篇 |
1996年 | 1篇 |
1992年 | 2篇 |
1991年 | 1篇 |
1990年 | 4篇 |
1989年 | 5篇 |
1988年 | 5篇 |
1987年 | 2篇 |
1986年 | 4篇 |
1985年 | 7篇 |
1984年 | 1篇 |
1982年 | 2篇 |
1981年 | 4篇 |
1978年 | 1篇 |
排序方式: 共有422条查询结果,搜索用时 31 毫秒
1.
2.
3.
4.
Siaghy EM Devaux Y Sfaksi N Carteaux JP Ungureanu-Longrois D Zannad F Villemot JP Burlet C Mertes PM 《Journal of molecular and cellular cardiology》2000,32(3):493-504
Adenosine is a potent vasodilator whose concentration has been shown to increase in cardiac tissue in response to hypoxia. However, the time-dependent relationship between the levels of myocardial interstitial adenosine and tissue oxygenation has not yet been completely established. Therefore, the purpose of this study was to investigate the complex relationship between tissue myocardial oxygen tension (PtiO(2)) and interstitial myocardial adenosine and lactate concentrations by developing a new technique which combines a cardiac microdialysis probe and a Clark-type P O(2)electrode. The combined and the single microdialysis probes were implanted in the left ventricular myocardium of anesthetized pigs. The consequences of the combined use of microdialysis and P O(2)probes on myocardial PtiO(2)and microdialysis performances against glucose were evaluated. A moderate but significant reduction in the relative recovery against glucose of the combined probe was observed when compared to that of the single microdialysis probe (42+/-2 v 32+/-1%, mean+/-S.E. M.n=5 P<0.05), at 2microl/min microdialysis probe perfusion flow. Similarly, myocardial oxygen enrichment, measured by the P O(2)electrode, was negligible when microdialysis probe perfusion flow was 2microl/min. Systemic hypoxia (FiO(2)=0.08) resulted in a significant decrease in PtiO(2)from 30+/-4 to 11+/-2 mmHg, limited increase in coronary blood flow (CBF), and a significant increase in myocardial adenosine and lactate concentrations from 0.34+/-0.05 to 0.98+/-0.06micromol/l and from 0.45+/-0.05 to 0.97+/-0.06 mmol/l respectively (P<0.05). Increasing the FiO(2)to 0.3 restored the PtiO(2)and hemodynamic parameters to baseline values with no changes in interstitial adenosine and lactate concentrations. Nevertheless, myocardial interstitial adenosine remained significantly higher than baseline values. In conclusion, this study demonstrates the ability of a combined probe to measure simultaneously regional myocardial PtiO(2)and metabolite concentration during hypoxia. The hypoxia-induced increase in myocardial adenosine persists after correction of hypoxia. The physiological significance of this observation requires further studies. 相似文献
5.
6.
Li Shen Pardeep S. Jhund Inder S. Anand Ankeet S. Bhatt Akshay S. Desai Aldo P. Maggioni Felipe A. Martinez Marc A. Pfeffer Adel R. Rizkala Jean L. Rouleau Karl Swedberg Muthiah Vaduganathan Orly Vardeny Dirk J. van Veldhuisen Faiez Zannad Michael R. Zile Milton Packer Scott D. Solomon John J.V. McMurray 《Journal of the American College of Cardiology》2021,77(16):1961-1973
BackgroundThe incidence of pneumonia and subsequent outcomes has not been compared in patients with heart failure and reduced ejection fraction (HFrEF) and preserved ejection fraction (HFpEF).ObjectivesThis study aimed to examine the rate and impact of pneumonia in the PARADIGM-HF (Prospective Comparison of Angiotensin Receptor-Neprilysin Inhibitor With Angiotensin Converting Enzyme Inhibitor to Determine Impact on Global Mortality and Morbidity in Heart Failure) and PARAGON-HF (Prospective Comparison of ARNI with ARB Global Outcomes in Heart Failure with Preserved Ejection Fraction) trials.MethodsThe authors analyzed the incidence of investigator-reported pneumonia and the rates of HF hospitalization, cardiovascular death, and all-cause death before and after the occurrence of pneumonia, and estimated risk after the first occurrence of pneumonia in unadjusted and adjusted analyses (the latter including N-terminal pro–B-type natriuretic peptide).ResultsIn PARADIGM-HF, 528 patients (6.3%) developed pneumonia after randomization, giving an incidence rate of 29 (95% CI: 27 to 32) per 1,000 patient-years. In PARAGON-HF, 510 patients (10.6%) developed pneumonia, giving an incidence rate of 39 (95% CI: 36 to 42) per 1,000 patient-years. The subsequent risk of all trial outcomes was elevated after the occurrence of pneumonia. In PARADIGM-HF, the adjusted hazard ratio (HR) for the risk of death from any cause was 4.34 (95% CI: 3.73 to 5.05). The corresponding adjusted HR in PARAGON-HF was 3.76 (95% CI: 3.09 to 4.58).ConclusionsThe incidence of pneumonia was high in patients with HF, especially HFpEF, at around 3 times the expected rate. A first episode of pneumonia was associated with 4-fold higher mortality. (Prospective Comparison of Angiotensin Receptor–Neprilysin Inhibitor With Angiotensin-Converting Enzyme Inhibitor to Determine Impact on Global Mortality and Morbidity in Heart Failure [PARADIGM-HF], NCT01035255; Prospective Comparison of ARNI [Angiotensin Receptor–Neprilysin Inhibitor] With ARB [Angiotensin Receptor Blocker] Global Outcomes in Heart Failure With Preserved Ejection Fraction [PARAGON-HF], NCT01920711) 相似文献
7.
8.
9.